Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Dexcom G7 is an important partner to GLP-1s Image shown does not include required overpatch
Other important safety considerations include: Risk of acute pancreatitis : Seek urgent medical attention for severe, persistent abdominal pain with or without vomiting [1] Gallbladder disease : Increased risk of gallstones and related complications Diabetic retinopathy : Caution in patients with pre-existing retinopathy due to rapid improvement in blood glucose control Hypoglycaemia : Increased risk when used with insulin or sulfonylureas, which may require dose reduction of these medications Oral contraceptive interaction : Reduced effectiveness due to delayed gastric emptying
These medications also work best alongside nutrition and activity changes
Depending on individual response, dosing may be adjusted to every ten days, every two weeks, or even longer
Similarly, sulfonylureas stimulate insulin release from the pancreas, and when combined with Semaglutide, they can increase the risk of hypoglycemia
When you reach a stable routine, you and your clinician can discuss maintenance : continuing the medication, tapering, or transitioning to a non-medication plan
